← All organizations

ObsEva SA

For profitWebsite ↗

Also known as: ObsEva SA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 23, 2020

Defunct as of Dec 31, 2025

Timeline

2010s

Jun 1, 2012
ObsEva SA— Founded

2020s

Dec 31, 2025
ObsEva SA— Defunct

Drugs by trial phase (7 distinct, 14 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT04372121Lead sponsorPhase 3Mar 23, 2020
NCT04335591Lead sponsorPhase 3Mar 5, 2020
NCT03992846Lead sponsorPhase 3Jun 13, 2019
NCT03962049Lead sponsorPhase 1May 31, 2019
NCT03961932Lead sponsorPhase 1May 31, 2019
NCT03986944Lead sponsorPhase 3May 23, 2019
NCT03986944Study directorPhase 3May 23, 2019
NCT03758885Lead sponsorPhase 3Jan 10, 2019
NCT03369262Lead sponsorPhase 2Jan 10, 2018
NCT03070951Lead sponsorPhase 3May 23, 2017
NCT03070899Lead sponsorPhase 3Apr 20, 2017
NCT03081208Lead sponsorPhase 3Mar 6, 2017
NCT02778399Lead sponsorPhase 2Jul 1, 2016
NCT02326142Lead sponsorPhase 2Mar 1, 2015
NCT02310802Lead sponsorPhase 2Nov 1, 2014

Details

Founded: Geneva, CH Jun 1, 2012
Last known activity: Mar 23, 2020